FDA Investigator Ibad U Khan
Ibad U Khan has conducted inspections on 41 sites in 1 countries as of 18 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
41
Last Inspection Date:
18 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Ibad U Khan:
Aaron P Wozniak,
Adam R Cooke,
Alaric C Denton,
Althea A Williams,
Amanda L Evanco,
Amy H Ruble,
Ana L Kewes,
Andrea L Williams Jones,
Ann B Borromeo,
April R Bowen,
Arie C Menachem,
Ayyappan Rathakrishnan,
Babatunde D Babalola,
Barbara T Carmichael,
Benjamin E Bowen,
Betsy C Galliher,
Bonita S Chester,
Brandy D Brown,
Brenda Rivera,
Brentley S Collins,
Brittny C Cargo,
Burnell M Henry,
Calvin B Koerner,
Calvin Foulks,
Carlos A Ortiz,
CDR Thomas R Berry, PPh,
Chateryl K Washington,
Cherrie A Zachary,
Cheryl Love Harris,
Christie A Beatty,
Christie B Rice,
Christopher B May,
Christopher S Keating,
Claudette D Brooks,
Constance Y Fears,
Cordelia J Brammer,
Crystal A Harlan,
Cynthia Jim, CSO,
Cyrus Agarabi, PhD,
D Ross Spears, PhD,
Daphne Santiago, PhD,
David E Lowe,
David T Glover,
David Williams,
Dawn M Braswell,
Deborah A Greco,
Dellarese L Herbert,
Demario L Walls,
Derek C Price,
Devaughn Edwards,
Donald C Obenhuber, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhihao Qiu (Peter), PhD,
Edward Deberry,
Edward E Lockwood (EEL),
Eileen J Bannerman,
Eric S Weilage,
Ernest H Blackwood,
Esra Toussaint,
Eural E Porter,
Frank Wackes,
Fulton A Varner,
Gabriel R Mclemore,
Gamal A Norton,
Gary E Coleman, Jr, REHS,
George T Allen, Jr,
Geraldine D Sanders,
Gilbert T Salud,
Hai Lient Phung,
Helen R Bester,
Inga M Warr,
Ingrid A Zambrana,
James R Evans,
Janet B Gray,
Jared P Stevens,
Jason F Chancey,
Jason K Morgan,
Jawaid Hamid,
Jeffrey D Sheppard,
Jennifer D Hollstrom,
Jessica Fields,
Jie He,
Jimmy O Buford,
John D Lloyd,
Johnetta F Walters,
Jonathan G Swoboda,
Jose Acruz Gonzalez,
Jose M Gonzalez,
Joseph F Owens,
Joseph Kutze, PhD,
Justin A Boyd,
Kamal N Tiwari,
Kara D Dobbin,
Karen A Coleman,
Kebire G Abraha,
Kenny R Robinson,
Kerry L Edwards, III,
Kimberly Cdelk Brooks,
Kip J Hanks,
Kirsten L Vadheim, PhD,
Kunapuli T Madhusudhan,
Laiza V Garcia,
Lareese K Thomas,
Larry K Hampton,
Latonya T Jiggetts,
Laura I Salazar, PhD,
Lauryl A Smith,
Leah M Andrews,
Lei Zhang, PhD,
Lesley K Satterwhite,
Leslie W Gilbert,
Lillie D Witcher,
Linda M Athey,
Lois K Gross,
Lorenzo Jones,
LT Daveta L Bailey,
LT Tamara J Henderson,
Luis A Carrion,
Luis Mburgos Medero,
Marcella D Crook,
Marian A Kainer,
Marie F Morin,
Marion Michaelis,
Marla A Cassidy,
Marvin D Jones,
Mary A Millner,
Matthew A Humbard,
Matthew G Brown,
Mcbean,
Melanie M Walker,
Melanie W Pishnery,
Miaja Umaedi,
Michael Shanks, MS,
Myoshi M Francis,
N'jere English,
Nicole E Knowlton,
Nije A Thomas,
Olumide A Martins,
Patricia F Hudson,
Paul A Bonneau,
Paul W Moy,
Penny H Mccarver,
Phillip M Pontikos,
Prabhu P Raju,
Priscilla M Pastrana,
Rachael L Cook,
Randy L Clarida,
Rashonda N Rucker,
Reba A Gates,
Rebecca Rodriguez,
Rhonda Alexander,
Robert C Coleman,
Robert D Tollefsen,
Robert Jennings,
Robert L Lewis, Jr,
Robert P Neligan,
Robin N Goins,
Ronnie E Jackson,
Safronia Jenkins,
Sally Gopaul,
Samantha J Bradley,
Samuel L Murray,
Sandra I Gaul,
Santos E Camara,
Sarah Forney,
Sayeeda Hdabe,
Seneca D Toms,
Sharna D Pratt,
Sharon K Thoma, PharmD,
Sidney B Priesmeyer,
Sonya M Edmonds,
Stephanie E Hubbard,
Susan M Jackson,
Susan O Oladeji,
Tamara M Casselman,
Tamika D Cathey,
Tammara A Stephens,
Teresa C Thompson,
Theresa L Stewart,
Thuy T Nguyen, LCDR,
Tomika L Bivens,
Tracy R Ball,
Trang N Cox,
Trang P Nguyen,
Vanessa E Coulter,
Vicky C Stoakes,
Victoria L Palmer,
Vincent M Williams,
Viviana Matta,
Wayne E Seifert,
Xiomara Copeland,
Yiyue Zhang (nmi), PhD,
Zhao Wang, PhD
Ibad U Khan's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2009 | EIR | Biogen MA Inc. - EIR, 2009-09-25 |
June, 2008 | FDA 483 | Hospira, Inc. - Form 483, 2008-06-13 |
June, 2010 | FDA 483 | Bausch & Lomb Incorporated - Form 483, 2010-06-25 |
October, 2009 | EIR | KBI Biopharma, Inc. - EIR, 2009-10-09 |
September, 2009 | FDA 483 | Perfecto Products Mfg Inc - Form 483, 2009-09-10 |
September, 2008 | FDA 483 | Novo Nordisk Pharmaceutical Industries, LP - Form 483, 2008-09-26 |
August, 2008 | FDA 483 | CSL Plasma, Inc - Form 483, 2008-08-29 |
December, 2009 | EIR | Alcami Carolinas Corporation - EIR, 2009-12-04 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more